Delirium Tremens: Causes, Risk Factors, and Treatment

Delirium tremens (DTs) is the most severe and potentially fatal form of alcohol withdrawal.

DTs produce sudden-onset seizures, vivid hallucinations, autonomic instability, and profound confusion in individuals with a history of heavy, prolonged alcohol use. They develop in approximately 3 to 5% of hospitalized patients undergoing alcohol withdrawal.

Symptoms typically emerge 48 to 96 hours after the last drink. Without medical intervention, delirium tremens carries a mortality rate of up to 37%. With appropriate treatment, that rate drops below 5%.

Recognizing the earliest warning signs, understanding exactly who is at risk, and knowing what medical treatment involves can be the difference between a managed withdrawal and a life-threatening emergency.

Key Takeaways

• Delirium tremens develops in approximately 3 to 5% of patients withdrawing from alcohol, according to research published in the New England Journal of Medicine, but the condition carries a mortality rate of up to 37% without treatment.
• The Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar) is the primary clinical tool used to measure alcohol withdrawal severity, with scores above 20 indicating severe withdrawal requiring intensive intervention.
• According to SAMHSA’s 2023 NSDUH, an estimated 29.5 million Americans aged 12 or older met diagnostic criteria for Alcohol Use Disorder in the past year.
• DTs result from abrupt removal of alcohol’s GABA-A receptor potentiation combined with unopposed glutamate excitotoxicity, producing a state of dangerous central nervous system hyperexcitability.
• Benzodiazepines (diazepam, lorazepam, chlordiazepoxide) remain the first-line pharmacological treatment for DTs, with symptom-triggered dosing guided by serial CIWA-Ar scoring.

What Is Delirium Tremens?

Delirium tremens is a medical emergency characterized by rapid-onset delirium, autonomic hyperactivity, and global confusion occurring as a complication of severe alcohol withdrawal in individuals with a history of chronic heavy drinking.

Clinical Definition and Classification

Delirium tremens occupies the most severe end of the alcohol withdrawal spectrum:

• ICD-10 classification: Delirium tremens is classified under F10.231 (Alcohol dependence with withdrawal delirium) in the International Classification of Diseases, distinguishing it from uncomplicated alcohol withdrawal (F10.230) and withdrawal with perceptual disturbances (F10.232).
• DSM-5-TR context: The DSM-5-TR classifies the underlying condition as Alcohol Use Disorder (AUD), with delirium tremens representing the most dangerous medical complication of physiological withdrawal from alcohol dependence.
• Mortality distinction: Unlike other forms of substance withdrawal, alcohol withdrawal through delirium tremens is directly life-threatening. The other substance class with comparable withdrawal mortality risk is benzodiazepine withdrawal, which shares the same underlying GABAergic mechanism.

The Triad of Delirium Tremens

DTs are clinically identified by three hallmark features occurring simultaneously:

• Delirium: Acute, fluctuating disturbance in attention, awareness, and cognition. Patients are disoriented to time, place, and person, and cannot sustain coherent thought.
• Tremor: Coarse, generalized tremor involving the hands, trunk, and tongue. Tremor intensity correlates with withdrawal severity and autonomic instability.
• Autonomic hyperactivity: Tachycardia (heart rate exceeding 100 bpm), hypertension, diaphoresis (profuse sweating), hyperthermia, and pupil dilation reflecting unopposed sympathetic nervous system activation.

Begin your journey to recovery with personalized drug & alcohol rehab—verify your insurance coverage in under a minute. Check your coverage online now.

What Causes Delirium Tremens?

Delirium tremens results from abrupt disruption of the brain’s neurochemical equilibrium after prolonged alcohol exposure has forced fundamental adaptations in inhibitory and excitatory neurotransmitter systems.

GABAergic Downregulation

Chronic alcohol exposure produces progressive downregulation of the brain’s primary inhibitory system:

• GABA-A receptor adaptation: Alcohol potentiates GABA-A receptor function, enhancing chloride ion flow and producing sedation, anxiolysis, and motor relaxation. Chronic exposure triggers compensatory receptor downregulation (fewer receptors, reduced receptor sensitivity) as the brain attempts to maintain homeostasis.
• Inhibitory deficit upon cessation: When alcohol is abruptly removed, the downregulated GABA system cannot produce sufficient inhibitory signaling to counterbalance normal excitatory activity. This inhibitory deficit is the primary driver of withdrawal hyperexcitability.

Glutamate Upregulation and Excitotoxicity

Simultaneously, the brain’s excitatory glutamate system undergoes reciprocal upregulation:

• NMDA receptor upregulation: Alcohol chronically blocks NMDA glutamate receptors. The brain compensates by increasing NMDA receptor density and sensitivity. When alcohol is removed, these upregulated receptors face unopposed glutamate stimulation.
• Excitotoxic cascade: The combination of deficient GABAergic inhibition and excessive glutamatergic excitation produces a state of dangerous central nervous system hyperexcitability that manifests as tremor, seizures, hallucinations, and autonomic instability.

Sympathetic Nervous System Dysregulation

Alcohol withdrawal disrupts autonomic nervous system balance:

• Catecholamine surge: Removal of alcohol’s depressant effect on the locus coeruleus (the brain’s primary norepinephrine-producing nucleus) triggers a surge in norepinephrine and epinephrine release, producing tachycardia, hypertension, diaphoresis, and hyperthermia.
• Hypothalamic-pituitary-adrenal axis activation: Alcohol withdrawal activates the HPA stress axis, elevating cortisol levels and compounding autonomic instability.

Start Your Journey to Wellness Today

Contact us today to schedule an initial assessment. We are here to help.

Call Us Now

Kindling Effect

Repeated episodes of alcohol withdrawal produce cumulative neurological sensitization:

• Progressive severity: Each withdrawal episode lowers the seizure threshold and increases the likelihood and severity of subsequent withdrawals. This kindling phenomenon, first described by researcher Robert Post, explains why patients with multiple prior withdrawal episodes face the highest DT risk.
• Clinical implication: A patient’s number of prior detox episodes is one of the strongest predictors of DT development during current withdrawal.

Risk Factors for Delirium Tremens

Not every individual who stops drinking develops delirium tremens. Specific clinical and demographic variables identify patients at highest risk.

Primary Risk Factors

The following factors most strongly predict DT development:

• History of delirium tremens: Prior DT episodes are the single strongest predictor of recurrence during subsequent withdrawals. The kindling effect ensures each episode increases neurological vulnerability.
• History of withdrawal seizures: Patients with prior seizure activity during alcohol withdrawal face elevated DT risk due to cumulative lowering of the seizure threshold.
• Duration and quantity of alcohol use: Daily heavy drinking (more than 8 standard drinks per day) sustained for more than 10 years produces the deepest neuroadaptive changes and highest DT risk.
• High CIWA-Ar score at presentation: CIWA-Ar scores above 20 at initial assessment correlate with increased risk of progression to DTs.

Secondary Risk Factors

Additional variables that elevate risk include:

• Co-occurring medical illness: Infections, electrolyte imbalances, hepatic dysfunction, and traumatic injuries during the withdrawal period increase DT probability.
• Age over 40: Older adults exhibit reduced neuroplasticity and slower neurochemical recovery, increasing vulnerability to severe withdrawal complications.
• Concurrent benzodiazepine or sedative use: Combined GABAergic substance dependence deepens the inhibitory deficit upon cessation.
• Malnutrition and thiamine deficiency: Chronic alcohol use depletes thiamine (vitamin B1). Thiamine deficiency compounds neurological injury and increases the risk of Wernicke encephalopathy co-occurring with DTs.

Are you covered for treatment?

• 

• 

• 

• 

• 

• 

• 

• 

Carolina Center for Recovery works with most major insurance providers to make high-quality care accessible and affordable.

Check Coverage Now!

Delirium Tremens Timeline and Stages

Alcohol withdrawal, including delirium tremens, follows a predictable timeline that begins within hours of the last drink and reaches maximum danger at 48 to 96 hours.

1. Stage 1: Minor Withdrawal (6 to 24 hours): Anxiety, insomnia, hand tremor, nausea, headache, diaphoresis, and elevated heart rate emerge as blood alcohol levels drop. Most patients experience only this stage.
2. Stage 2: Alcoholic Hallucinosis (12 to 48 hours): Visual, auditory, or tactile hallucinations develop while the patient retains orientation and awareness that the hallucinations are not real. This stage does not constitute delirium tremens.
3. Stage 3: Withdrawal Seizures (24 to 48 hours): Generalized tonic-clonic seizures occur in approximately 10% of patients undergoing alcohol withdrawal. Seizures may occur in clusters and precede DT onset by 6 to 24 hours.
4. Stage 4: Delirium Tremens (48 to 96 hours): Full DT syndrome emerges with global confusion, disorientation, agitation, vivid hallucinations (often visual, frequently involving insects or small animals), severe autonomic instability, and profound tremor. DTs peak at 72 to 96 hours and typically resolve within 5 to 7 days with treatment. Without treatment, DTs can persist for up to 14 days and are fatal in up to 37% of cases.

Symptoms of Delirium Tremens

Delirium tremens produces symptoms across multiple organ systems simultaneously, reflecting the widespread effects of CNS hyperexcitability.

Common DT Symptoms

Core symptoms present in the majority of DT cases:

• Global confusion and disorientation: Patients cannot identify where they are, what day it is, or who is around them. Attention fluctuates unpredictably.
• Visual hallucinations: The hallmark perceptual disturbance of DTs. Patients frequently report seeing insects, animals, or people that are not present. These hallucinations are experienced as completely real, unlike those in alcoholic hallucinosis.
• Severe tremor: Coarse, generalized tremor involving the entire body, most prominent in the hands and worsened by voluntary movement.
• Profuse diaphoresis: Drenching sweating driven by sympathetic hyperactivity, contributing to dangerous fluid and electrolyte losses.

Rediscover Life at Carolina Center for Recovery

At Carolina Center for Recovery, we’re here to help you or your loved one take the first step toward lasting recovery and a brighter future.

Our Team

Severe and Life-Threatening Symptoms

Symptoms requiring immediate intensive medical intervention:

• Tonic-clonic seizures: Grand mal seizures occurring during DTs carry risk of status epilepticus (continuous seizure activity), aspiration, traumatic injury, and respiratory arrest.
• Hyperthermia: Core body temperature exceeding 104°F (40°C) indicates severe autonomic dysregulation and correlates with increased mortality risk.
• Cardiovascular collapse: Extreme tachycardia, hypertensive crisis, or arrhythmia can produce myocardial ischemia, stroke, or cardiac arrest.
• Respiratory failure: Severe agitation combined with aspiration risk, metabolic acidosis, and exhaustion can produce respiratory compromise.

When Delirium Tremens Becomes Fatal

DT-related death results from specific physiological cascades:

• Cardiac arrhythmia: Electrolyte depletion (magnesium, potassium, phosphate) combined with catecholamine surge produces lethal cardiac rhythm disturbances.
• Aspiration pneumonia: Vomiting during altered consciousness leads to aspiration of gastric contents into the lungs.
• Hyperthermia and rhabdomyolysis: Uncontrolled muscle activity produces dangerous core temperature elevation and skeletal muscle breakdown, releasing myoglobin that damages the kidneys.

How Delirium Tremens Is Diagnosed

Delirium tremens is diagnosed clinically based on presenting symptoms, patient history, and validated assessment scoring.

Begin your journey to recovery with personalized drug & alcohol rehab—verify your insurance coverage in under a minute. Check your coverage online now.

The CIWA-Ar Scale

The Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar), developed by Sullivan et al., is the standard tool for grading alcohol withdrawal severity:

• 10-item assessment: The CIWA-Ar measures nausea/vomiting, tremor, paroxysmal sweats, anxiety, agitation, tactile disturbances, auditory disturbances, visual disturbances, headache, and orientation/clouding of sensorium.
• Scoring interpretation: Scores below 10 indicate mild withdrawal managed with supportive care. Scores of 10 to 18 indicate moderate withdrawal. Scores above 20 indicate severe withdrawal with high risk of DT progression, requiring aggressive pharmacological intervention and continuous monitoring.
• Symptom-triggered protocol: Serial CIWA-Ar scoring every 1 to 2 hours allows clinicians to administer benzodiazepines only when objective symptoms exceed predetermined thresholds, reducing total medication exposure while maintaining safety.

Differential Diagnosis

Several conditions mimic delirium tremens and must be excluded:

• Wernicke encephalopathy: Thiamine deficiency produces confusion, ophthalmoplegia (eye movement paralysis), and ataxia (gait instability). Co-occurs with DTs in malnourished alcohol-dependent patients.
• Hepatic encephalopathy: Liver failure produces delirium through ammonia accumulation, mimicking DTs in patients with alcoholic cirrhosis.
• Sepsis: Systemic infection produces delirium, fever, and tachycardia that overlap with DT presentation. Blood cultures and infection workup are mandatory.
• Traumatic brain injury: Alcohol-dependent individuals frequently sustain head injuries during falls. Subdural hematoma must be excluded by imaging.

Treatment for Delirium Tremens

Delirium tremens requires intensive medical treatment in a monitored setting. The goal is to prevent seizures, control autonomic instability, and support the patient through the withdrawal period safely.

Start Your Journey to Wellness Today

Contact us today to schedule an initial assessment. We are here to help.

Call Us Now

First-Line Pharmacological Treatment: Benzodiazepines

Benzodiazepines are the standard of care for DT management:

• Mechanism: Benzodiazepines directly potentiate GABA-A receptor function, partially replacing the GABAergic activity lost when alcohol is removed. This directly addresses the neurochemical imbalance driving DTs.
• Preferred agents: Diazepam (Valium) and chlordiazepoxide (Librium) are preferred for their long half-lives and self-tapering pharmacokinetics. Lorazepam (Ativan) is preferred in patients with hepatic impairment because it does not require hepatic metabolism.
• Dosing protocol: Symptom-triggered dosing guided by serial CIWA-Ar assessment reduces total benzodiazepine exposure by 60 to 70% compared to fixed-schedule dosing, according to research by Saitz et al. published in JAMA.

Adjunct Medications

Additional medications address specific DT complications:

• Thiamine (vitamin B1): Intravenous thiamine (200 to 500 mg) is administered before glucose to prevent precipitation of Wernicke encephalopathy. Thiamine is given to every patient with suspected heavy alcohol use.
• Magnesium sulfate: Replaces the magnesium depleted by chronic alcohol use and reduces seizure risk.
• Phenobarbital: Used as a second-line agent for benzodiazepine-resistant DTs, providing additional GABAergic activity through a different binding site on the GABA-A receptor complex.
• Electrolyte replacement: Aggressive correction of hypokalemia, hypomagnesemia, and hypophosphatemia prevents cardiac arrhythmia and rhabdomyolysis.

Emerging and Investigational Treatments

Newer approaches to refractory DTs are under investigation:

• Dexmedetomidine: This alpha-2 adrenergic agonist reduces sympathetic hyperactivity without respiratory depression, making it useful as an adjunct in ICU-managed DTs.
• Ketamine: Low-dose ketamine infusion addresses the glutamatergic excitotoxicity component of DTs directly through NMDA receptor antagonism. Early evidence supports its use in benzodiazepine-resistant cases.
• Carbamazepine: Used in some European protocols as an alternative to benzodiazepines for mild to moderate withdrawal, though it lacks sufficient evidence for severe DTs.

Are you covered for treatment?

• 

• 

• 

• 

• 

• 

• 

• 

Carolina Center for Recovery works with most major insurance providers to make high-quality care accessible and affordable.

Check Coverage Now!

Treatment at South Carolina Addiction Treatment

South Carolina Addiction Treatment provides medically supervised alcohol detox through its SCAT2Track program in Simpsonville, South Carolina, offering 24-hour clinical monitoring essential for safe alcohol withdrawal management.

Medical Detox (Track One)

Track One delivers 7-day medically supervised detoxification for alcohol withdrawal:

• 24-hour medical monitoring: Licensed nursing staff and psychiatric providers monitor withdrawal symptoms around the clock using CIWA-Ar scoring protocols in a 16-bed CARF-accredited facility, with the medical team led by Dr. Gergana Dimitrova, MD.
• Comprehensive assessment battery: All clients complete four core assessments (nursing assessment, biopsychosocial, history and physical, and psychiatric evaluation) within the first 24 hours to identify DT risk factors and co-occurring conditions.

“Alcohol withdrawal is one of the few withdrawal syndromes that can be directly life-threatening. Early identification of high-risk patients through validated assessment tools like the CIWA-Ar allows our medical team to intervene before symptoms escalate to delirium tremens.”

— Dr. Gergana Dimitrova, MD, Medical Director, South Carolina Addiction Treatment

Residential Treatment (Track Two)

Track Two extends care to 14 total days with structured clinical programming:

• Clinical transition: After medical stabilization, clients step into individual counseling, cognitive behavioral therapy, group therapy, and 12-step facilitation led by Pam DeHart, MA, LPC, LAC, ADC, Clinical Supervisor.
• Aftercare coordination: The clinical case manager connects graduating clients with PHP, IOP, and sober living programs within a 2.5-hour radius.

Rediscover Life at Carolina Center for Recovery

At Carolina Center for Recovery, we’re here to help you or your loved one take the first step toward lasting recovery and a brighter future.

Our Team

Frequently Asked Questions

What is the triad of delirium tremens?

The triad of delirium tremens consists of delirium (acute confusion with fluctuating awareness), tremor (coarse generalized shaking), and autonomic hyperactivity (tachycardia, hypertension, hyperthermia, profuse sweating). All three features must be present simultaneously for a clinical diagnosis of DTs rather than uncomplicated alcohol withdrawal.

What do the DTs look like?

A person experiencing DTs appears profoundly confused, agitated, and drenched in sweat. They may be reaching for or swatting at objects that are not visible to others (visual hallucinations). Severe whole-body tremor is visible, and vital signs show dangerously elevated heart rate and blood pressure.

How long does delirium tremens last?

Delirium tremens typically begins 48 to 96 hours after the last drink, peaks at 72 to 96 hours, and resolves within 5 to 7 days with appropriate medical treatment. Without treatment, DTs can persist for up to 14 days and carry a mortality rate approaching 37%.

Begin your journey to recovery with personalized drug & alcohol rehab—verify your insurance coverage in under a minute. Check your coverage online now.

What causes delirium tremens?

DTs result from abrupt removal of alcohol’s potentiating effect on GABA-A receptors combined with unopposed glutamate excitotoxicity from upregulated NMDA receptors. This neurochemical imbalance produces dangerous central nervous system hyperexcitability that manifests as seizures, hallucinations, and autonomic instability.

Can you die from delirium tremens?

Delirium tremens is fatal in up to 37% of untreated cases, making it one of the most dangerous withdrawal syndromes. Death results from cardiac arrhythmia, respiratory failure, hyperthermia, or aspiration pneumonia. With appropriate medical treatment including benzodiazepines and intensive monitoring, mortality drops below 5%.

When does delirium tremens start after stopping drinking?

Delirium tremens typically begins 48 to 96 hours after the last alcoholic drink, following a progression through minor withdrawal symptoms (6 to 24 hours), possible hallucinations (12 to 48 hours), and potential seizures (24 to 48 hours). DTs represent the final and most severe stage of the withdrawal timeline.

Who is at highest risk for delirium tremens?

Individuals with prior DT episodes, prior withdrawal seizures, more than 10 years of heavy daily drinking, concurrent medical illness, age over 40, and CIWA-Ar scores above 20 at presentation face the highest risk. A history of multiple prior detox attempts (kindling effect) is the strongest single predictor.

Start Your Journey to Wellness Today

Contact us today to schedule an initial assessment. We are here to help.

Call Us Now

How is delirium tremens treated?

Benzodiazepines (diazepam, lorazepam, chlordiazepoxide) are the first-line pharmacological treatment, administered using symptom-triggered dosing guided by serial CIWA-Ar scoring. Adjunct treatments include intravenous thiamine, magnesium sulfate, electrolyte replacement, and phenobarbital for refractory cases. Treatment requires continuous monitoring in a medical facility.

References

1. Schuckit, M. A. (2014). Recognition and management of withdrawal delirium (delirium tremens). New England Journal of Medicine, 371(22), 2109-2113.
2. Substance Abuse and Mental Health Services Administration. (2024). Key substance use and mental health indicators in the United States: Results from the 2023 NSDUH. https://www.samhsa.gov/data/report/2023-nsduh-annual-national-report
3. National Institute on Alcohol Abuse and Alcoholism. (2024). Alcohol use disorder: A comparison between DSM-IV and DSM-5. National Institutes of Health. https://www.niaaa.nih.gov/
4. Sullivan, J. T., Sykora, K., Schneiderman, J., Naranjo, C. A., & Sellers, E. M. (1989). Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). British Journal of Addiction, 84(11), 1353-1357.
5. Saitz, R., Mayo-Smith, M. F., Roberts, M. S., Redmond, H. A., Bernard, D. R., & Calkins, D. R. (1994). Individualized treatment for alcohol withdrawal: A randomized double-blind controlled trial. JAMA, 272(7), 519-523.
6. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Publishing.
7. Centers for Disease Control and Prevention. (2024). Alcohol-related disease impact. https://www.cdc.gov/alcohol/
8. Post, R. M. (2007). Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neuroscience & Biobehavioral Reviews, 31(6), 858-873.